Great Valley Advisor Group Inc. Has $746,000 Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Great Valley Advisor Group Inc. grew its position in IQVIA Holdings Inc. (NYSE:IQV) by 64.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 3,223 shares of the medical research company’s stock after purchasing an additional 1,261 shares during the period. Great Valley Advisor Group Inc.’s holdings in IQVIA were worth $746,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Berry Wealth Group LP bought a new stake in IQVIA during the 4th quarter worth about $531,000. Brighton Jones LLC acquired a new position in IQVIA in the fourth quarter valued at approximately $201,000. Mission Wealth Management LP bought a new position in IQVIA in the fourth quarter valued at approximately $360,000. Silver Oak Securities Incorporated grew its holdings in IQVIA by 1,046.8% during the 4th quarter. Silver Oak Securities Incorporated now owns 2,844 shares of the medical research company’s stock worth $658,000 after acquiring an additional 2,596 shares during the period. Finally, Stonebrook Private Inc. bought a new stake in shares of IQVIA during the 4th quarter valued at $706,000. Institutional investors own 89.62% of the company’s stock.

Analyst Ratings Changes

IQV has been the subject of a number of analyst reports. Barclays lifted their price objective on IQVIA from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. SVB Leerink started coverage on IQVIA in a research note on Monday, February 26th. They issued an “outperform” rating and a $290.00 price target for the company. Evercore ISI cut their price target on shares of IQVIA from $275.00 to $250.00 and set an “outperform” rating on the stock in a research report on Friday. BTIG Research began coverage on shares of IQVIA in a report on Tuesday, February 13th. They set a “buy” rating and a $285.00 price objective for the company. Finally, UBS Group increased their target price on shares of IQVIA from $240.00 to $300.00 and gave the stock a “buy” rating in a report on Thursday, February 15th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, IQVIA currently has a consensus rating of “Moderate Buy” and a consensus price target of $257.57.

Insider Transactions at IQVIA

In other news, insider Eric Sherbet sold 1,000 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $241.50, for a total value of $241,500.00. Following the sale, the insider now owns 20,836 shares of the company’s stock, valued at $5,031,894. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other IQVIA news, insider Eric Sherbet sold 1,000 shares of IQVIA stock in a transaction on Friday, February 16th. The shares were sold at an average price of $241.50, for a total value of $241,500.00. Following the sale, the insider now directly owns 20,836 shares in the company, valued at approximately $5,031,894. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kevin C. Knightly sold 8,607 shares of the stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $250.17, for a total transaction of $2,153,213.19. Following the transaction, the insider now owns 5,251 shares of the company’s stock, valued at $1,313,642.67. The disclosure for this sale can be found here. Insiders sold 41,285 shares of company stock valued at $10,331,003 in the last ninety days. 1.60% of the stock is currently owned by corporate insiders.

IQVIA Price Performance

Shares of NYSE IQV opened at $223.37 on Friday. The company has a fifty day moving average price of $244.08 and a 200 day moving average price of $224.01. The firm has a market cap of $40.54 billion, a PE ratio of 30.52, a PEG ratio of 2.16 and a beta of 1.52. The company has a current ratio of 0.88, a quick ratio of 0.86 and a debt-to-equity ratio of 2.02. IQVIA Holdings Inc. has a 1-year low of $167.42 and a 1-year high of $261.73.

IQVIA (NYSE:IQV) last posted its quarterly earnings data on Wednesday, February 14th. The medical research company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.82 by $0.02. IQVIA had a return on equity of 29.17% and a net margin of 9.01%. The company had revenue of $3.87 billion during the quarter, compared to analysts’ expectations of $3.80 billion. During the same period in the prior year, the firm earned $2.54 earnings per share. IQVIA’s revenue for the quarter was up 3.5% compared to the same quarter last year. Research analysts predict that IQVIA Holdings Inc. will post 10.12 earnings per share for the current fiscal year.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.